Low doses of sarizotan reduce dyskinesias and maintain antiparkinsonian efficacy of l-Dopa in parkinsonian monkeys
Laurent Grégoire, Pershia Samadi, Julie Graham, Paul J. Bédard, Gerd D. Bartoszyk, Thérèse Di PaoloVolume:
15
Year:
2009
Language:
english
DOI:
10.1016/j.parkreldis.2008.11.001
File:
PDF, 898 KB
english, 2009